Compare PI & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PI | ATRC |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 1.6B |
| IPO Year | 2016 | 2005 |
| Metric | PI | ATRC |
|---|---|---|
| Price | $145.82 | $42.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $222.75 | $52.00 |
| AVG Volume (30 Days) | ★ 558.7K | 554.8K |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $359,795,000.00 | ★ $518,304,999.00 |
| Revenue This Year | $1.30 | $16.90 |
| Revenue Next Year | $22.70 | $12.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.24 | ★ 15.80 |
| 52 Week Low | $60.85 | $28.29 |
| 52 Week High | $247.06 | $43.11 |
| Indicator | PI | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 70.06 |
| Support Level | $156.16 | $38.92 |
| Resistance Level | $173.98 | $42.42 |
| Average True Range (ATR) | 7.69 | 1.67 |
| MACD | 0.13 | 0.63 |
| Stochastic Oscillator | 3.81 | 94.89 |
Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.